In the first half of 2015, through programs supported by The Global Fund, another 500,000 people were put on antiretroviral treatment for HIV, bringing the total to date to 8.6 million, a 7% increase over end-2014 results.
Programs supported by the Global Fund have saved 17 million lives up to the end of 2014, according to the Results Report 2015 released by the Fund on 21 September. The Fund says that it is on track to reach 22 million lives saved by December 2016, the end of the current replenishment period (see graphic).
I was in Nairobi recently to help Aidspan facilitate a meeting with the representatives of about 30 organizations from East and Southern Africa involved in the monitoring of global health programs.
A draft of a new Corporate Key Performance Indicator (KPI) Framework 2013–2016 was presented to the Global Fund Board for review and discussion at the 29th Board meeting just concluded in Sri Lanka.
A number of strategic high-impact activities were not implemented during Phase 1 of a Round 8 TB grant in the Republic of Congo, and a significant portion of the budget was not spent, according to the Global Fund’s Grant Renewals Panel. Nevertheless, the Global Fund Board has approved new funding of $234,687 for Phase 2 of the grant. The overall Phase 2 budget recommended by the panel was approximately $2 million.
Of the approximately 80 million insecticide-treated nets distributed through Global Fund–supported programmes in 2012, about 66 million (73%) went to sub-Saharan African countries. This is well below half the 150 million insecticide-treated nets that the World Health Organisation estimates are needed annually to protect all populations at risk of malaria in this region.
TB mortality has decreased significantly since 2000 and treatment success rates have shown steady improvement. More than half of the countries that have received Global Fund support are on track to meet the international targets for case detection, treatment success, and TB disease incidence. However, multi-drug-resistant TB (MDR-TB) remains a critical threat.
Significant progress has been achieved in providing antiretroviral therapy (ART) and preventing mother-to-child transmission of HIV (PMTCT), but low antenatal care coverage and other health systems and gender-related challenges are hampering further progress on these fronts.
In preparation for the Fourth Replenishment meetings, the Global Fund has a published an “Update on Results and Impact.” This article provides some of the highlights of the report; more details are provided in separate articles on each of the three diseases.